The first Provention Bio trade was made in Q1 2019.
Since then Ken Griffin bought shares eight more times and sold shares on five occasions. The investor sold all their shares in Q2 2023 and doesn't own any shares in Provention Bio anymore.
Avg closing price
Price range
Sold -521 Thousand shares
Q2 2023
Avg closing price
$24.37
Price range
$24.23
-
$24.98
Increased shares by 1117.3% (+478 Thousand shares)
Q1 2023
Avg closing price
$12.55
Price range
$6.70
-
$24.21
Sold 81.7% shares (-191 Thousand shares)
Q4 2022
Avg closing price
$8.07
Price range
$4.52
-
$10.57
Increased shares by 59.8% (+87.5 Thousand shares)
Q3 2022
Avg closing price
$4.56
Price range
$3.43
-
$5.62
Increased shares by 208.1% (+98.9 Thousand shares)
Q2 2022
Avg closing price
$4.74
Price range
$3.66
-
$7.30
Sold 70.9% shares (-116 Thousand shares)
Q1 2022
Avg closing price
$5.98
Price range
$3.40
-
$7.88
Increased shares by 15.7% (+22.1 Thousand shares)
Q4 2021
Avg closing price
$6.35
Price range
$5.59
-
$7.39
Sold 18.7% shares (-32.5 Thousand shares)
Q3 2021
Avg closing price
$6.43
Price range
$5.66
-
$8.33
Increased shares by 14.4% (+21.8 Thousand shares)
Q2 2021
Avg closing price
$8.07
Price range
$6.71
-
$11.04
Increased shares by 144.7% (+89.8 Thousand shares)
Q1 2021
Avg closing price
$14.07
Price range
$10.12
-
$19.45
Increased shares by 91.4% (+29.6 Thousand shares)
Q3 2020